NeoGenomics, Inc. (NASDAQ:NASDAQ:NEO) Q1 2022 Earnings Conference Call April 27, 2022, 08:30 AM ET Company Participants Lynn Tetrault - Executive Chair & Principal Executive Officer.
FT. MYERS, FL / ACCESSWIRE / November 30, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced
NeoGenomics To Participate In The Stephens Annual Investment Conference 2021 tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.